Global Custom Market Research Reports Provider Company

phone

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 39
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Alzheimers Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation that offers funds for drug discovery and development research programs in the field of Alzheimers disease, related dementias and cognitive aging. The foundation offers services and support for development of drugs to prevent, treat, and cure Alzheimers disease. It offers grants to the recipients for the treatment of Alzheimers disease. The foundation offers funds on preclinical research and early-stage clinical trials for new drug targets. It partners with various universities, and other research and development organizations. ADDF is headquartered in New York, the US.

Alzheimers Drug Discovery Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Partnerships 13
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimers Disease Drugs 13
Equity Offering 14
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimers Drug Discovery Foundation - Key Competitors 15
Alzheimers Drug Discovery Foundation - Key Employees 16
Alzheimers Drug Discovery Foundation - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Government and Public Interest 18
Mar 28, 2018: Alzheimers Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2018 ADDF-Harrington Scholar Award 18
Mar 13, 2018: Funding Supports New Approaches to Treat Multiple Types of Dementia 19
Jan 09, 2018: Alzheimers Drug Discovery Foundation: $2.5 Million in New Grants Advance Clinical Trials of Alzheimers Treatments 20
Jan 08, 2018: Alzheimers Drug Discovery Foundation: $1.8 Million in New Funding Supports Clinical Stage Treatments 21
Jan 08, 2018: $1.8 Million in New Funding Supports Clinical Stage Treatments 23
Nov 14, 2017: Alzheimers Drug Discovery Foundation Announces Three New Grants 25
Sep 12, 2017: Three New Grants Support Promising Treatments for Alzheimers Disease 26
Sep 05, 2017: New Funding Supports Blood Test for Early Alzheimers 27
May 15, 2017: $2.6 Million in New Grants Spurs Innovation 28
Apr 20, 2017: ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimers and FTD 31
Mar 07, 2017: $4 Million in New Grants Support Several First-in-class Dementia Treatments 32
Mar 01, 2017: Cypralis Announces Grant Award from Alzheimers Drug Discovery Foundation 35
Product News 36
Nov 01, 2017: New Report Highlights Innovation in Alzheimers Clinical Trials 36
Jun 07, 2017: The Alzheimers Drug Discovery Foundation and Science Exchange Launch ADDF ACCESS to Advance CNS Research 37
Other Significant Developments 38
Jun 07, 2017: ADDF and Science Exchange Launch ADDF ACCESS to Advance Research 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

List of Tables
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimers Drug Discovery Foundation, Deals By Therapy Area, 2012 to YTD 2018 8
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
M3 Biotechnology Raises USD15.2 Million in Venture Financing 10
M3 Biotech Raises USD1.4 Million in Second Round of Venture Financing 12
Alzheimer Drug Discovery Enters into Research Agreement with CTI for Alzheimers Disease Drugs 13
Oryzon Genomics Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 14
Alzheimers Drug Discovery Foundation, Key Competitors 15
Alzheimers Drug Discovery Foundation, Key Employees 16

List Of Figures

List of Figures
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Alzheimers Drug Discovery Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

REASONS FOR DOING THE STUDY Alzheimers disease cannot be prevented, cured or slowed, and it is a rapidly growing and serious health problem, affecting more than 17 million worldwide. Therapies for

View Report

Alzheimers Disease: Competitive Landscape to 2026 Alzheimers disease (AD) is a progressive neurodegenerative disease that is characterized by memory loss, cognitive impairment, and functional decline. The degeneration of neurons starts in

View Report

Alzheimers Disease - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Alzheimers Disease - Pipeline Review, H2 2018, provides an overview of the Alzheimers Disease

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports